ELIZABETH TUCCIARONE: Open Payments
NPI 1063791416 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$601 in 34 payments from 13 companies in 2025. Trend: 2023 $537 · 2024 $510 · 2025 $601
Food & beverage: $601
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $166 |
| GlaxoSmithKline, LLC. | 8 | $134 |
| Lilly USA, LLC | 3 | $50 |
| Viatris Specialty LLC | 2 | $37 |
| Exact Sciences Corporation | 2 | $37 |
| Amgen Inc. | 2 | $33 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Verona Pharma, Inc. | 1 | $27 |
| ABBVIE INC. | 1 | $20 |
| PFIZER INC. | 1 | $18 |
Products named: TRELEGY ELLIPTA, Rybelsus, MOUNJARO, Wegovy, YUPELRI, Cologuard Collection Kit, OTEZLA, AIRSUPRA.
Industry payments across PA — which companies pay providers there.
